Stockchase Opinions

Allan MeyerOpen TextOTEX.TOCOMMENTApr 01, 2016

Trading at less than 3X Price to Book. Looks attractive on a P/E basis and has great free cash flow value to enterprise value. Likes in the short term, but wouldn’t treat this as a hold for 5 – 10 years.

$67.38

Stock price when the opinion was issued

$32.10

As of May 28, 2026. Market Open.

computer softwareprocessing
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

DON'T BUY

Big selloff. At the centre of disruption by AI ecosystem. A lot of the software pricing models will change because now there's an alternative -- not necessarily "rip and replace", but contract renewals are much shorter. A lot of that churn will happen at the end of 2026.

A prove-me story. Change in leadership. These stocks look like value stocks, but at some point they become cheap for a reason.

TRADE

Its long-term pattern has broken down and has broken below $55 instead of rebounding. It's now consolidating and could return to its former low, bad news for long-term investors, but good for traders.

DON'T BUY

Look elsewhere for other software that has sold off due to AI fears and that are growing faster. Open Text's growth has been through acquisition but it has not had a lot of success with it.

DON'T BUY

Not at the top of his software list. Organic growth is somewhat non-existent at 1-2%. Acquisitions stretched the balance sheet.

Instead, look to the US at ADBE, CRM. Or LSPD and SHOP in Canada. See his Top Picks.

SELL ON STRENGTH

Factors weighing on stock include AI. M&A is great, but de-leveraging has been a headwind. Slow organic growth. Management shuffle. Other companies provide better businesses, better execution track record, industry-leading solutions, and trusted management.

Room for some recovery, so you could wait for a bounce. Better opportunities to deploy capital.

DON'T BUY

He's traded this one over the years. But even down at this level, it's yet another software company. You have to let a couple of quarters pan out. Probably working hard to integrate AI agents into software. It does more information resource management than the planning, so it's a little less susceptible to the large-language models.

Price target may be enticing, but he wouldn't put money in.

(Analysts’ price target is $49.00)
SELL
Reports tomorrow.

Hasn't owned for a number of years -- mainly because there are lots of good tech companies, with the bulk of them outside Canada. They'd have a better path to good results. Take a look at MSFT, for example.

Suffering pain along with most software companies, which have been hit unless they report amazing earnings. He'd be careful. He'd probably repurpose that capital, and look for a higher-quality company at a better valuation.

BUY ON WEAKNESS

No growth. They did well buying then spinning out Microfocus. Why isn't there a new CEO? They should buyback shares. It's on a short leash for him. Not a fan of their operations, but it's been so beaten up he would buy it now.

SELL
Biggest laggard in the investor's portfolio.

AI is starting to impinge on software businesses, which will hamper ability to sell as much or for as much profit. These stocks will continue to struggle over the next couple of years until they can prove that they can provide something over and above what AI may be taking away from them. 

Last summer his team exited their software companies completely.

DON'T BUY

Doesn't know it well, but the market fears that AI will replace these software companies. OTEX is trying to unload 15-20% of their business to be more AI-centric. He doesn't know if they will succeed or not. In this sector, he finds Salesforce more interesting, would avoid Oracle for its debt, and fears that Adobe's debt isn't wide enough. He prefers more senior software companies.

DON'T BUY

Wouldn't want to see it break the old support level. Already fallen a chunk. Are you going to hold on for another couple of bucks? Maybe, if you like the stock. Will probably find some support around $45-46. Definitely wouldn't step in. 

If you hold, have to decide if you want to wait to see if it can hold at next support level.

premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Jan 23/25, Up 16.6%)Stockchase Research Editor: Michael O'Reilly

Our PAST TOP PICK with OTEX has triggered its stop at $48.  To remain disciplined, we recommend covering the position at this time.  

premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Jan 23/25, Up 34.4%)Stockchase Research Editor: Michael O'Reilly

Our PAST TOP PICK with OTEX is progressing well.  To remain disciplined we recommend trailing up the stop (from $42) to $48 at this time.

BUY ON WEAKNESS

If you own it, hold on, but look for places to add at better levels -- $33 and, if you're really lucky ~$29. Embraced AI in a big way, which is expanding its own business as well as its clients. Able to maintain double-digit recurring growth rate.

His caveat is that, from the charts, price action not all that good. 

DON'T BUY

Horrible valuation versus peers. Hodge-podge of different software businesses, execution problems. Lots of debt. Management changes. Momentum is negative most of the time. Value trap.